Association between CD24 Ala/Val polymorphism and multiple sclerosis risk: A meta analysis. Issue 15 (April 2020)

• Record Type: Journal Article
• Authors: Yang, Wan; Zhou, Wang; Zhang, Bo-Kang; Kong, Ling-Suo; Zhu, Xing-Xing; Wang, Rui-Xiang; Yang, Yue; Chen, Yun-Fei; Chen, Lan-Ren
• Other Names: Das. Undurti N. section editor.
• Is Part Of: Medicine. Volume 99:Issue 15(2020)
• Publication Date: 2020-04
• Subjects: CD24 -- meta-analysis -- multiple sclerosis -- polymorphism; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000019530
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract: Background: The aim of this study was to explore the association between CD24 Ala/Val polymorphism and susceptibility of multiple sclerosis (MS). Methods: A comprehensive literature search for relevant studies was performed on google scholar, PubMed, Web of science, Embase, the Chinese National Knowledge Infrastructure and the Chinese Biology Medicine. This meta-analysis was conducted using the STATA 11.0 software and the pooled odds ratio with 95% confidence interval was calculated. Results: Seven case-control studies were included in this meta-analysis. The results showed significant association between CD24 Ala/Val polymorphism and susceptibility to MS. Stratified analysis by areas also showed significant association in Asians. However, no association was found in Europeans. Conclusion: This study suggested that the CD24 Val allele was associated with an increased risk of MS and larger-scale studies of populations are needed to explore the role of CD24 Ala/Val polymorphism during the pathogenesis of MS.